PADME: A Deep Learning-based Framework for Drug-Target Interaction Prediction
Open accessThe DOI matches its OpenAlex record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
In silico drug-target interaction (DTI) prediction is an important and challenging problem in biomedical research with a huge potential benefit to the pharmaceutical industry and patients. Most existing methods for DTI prediction including deep learning models generally have binary endpoints, which could be an oversimplification of the problem, and those methods are typically unable to handle cold-target problems, i.e., problems involving target protein that never appeared in the training set. Towards this, we contrived PADME (Protein And Drug Molecule interaction prEdiction), a framework based on Deep Neural Networks, to predict real-valued interaction strength between compounds and proteins without requiring feature engineering. PADME takes both compound and protein information as inputs, so it is capable of solving cold-target (and cold-drug) problems. To our knowledge, we are the first to combine Molecular Graph Convolution (MGC) for compound featurization with protein descriptors for DTI prediction. We used multiple cross-validation split schemes and evaluation metrics to measure the performance of PADME on multiple datasets, including the ToxCast dataset, and PADME consistently dominates baseline methods. The results of a case study, which predicts the binding affinity between various compounds and androgen receptor (AR), suggest PADME's potential in drug development. The scalability of PADME is another advantage in the age of Big Data.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
LeCun, Y., Bengio, Y., & Hinton, G. (2015) · Nature · doi:10.1038/nature14539 · Cited by 84,126
The protein kinase complement of the human genome
Manning, G., Whyte, D. B., Martinez, R., Hunter, T., & Sudarsanam, S. (2002) · Science · doi:10.1126/science.1075762 · Cited by 8,145
PubChem 2019 update: improved access to chemical data
Kim, S., Chen, J., Cheng, T., Gindulyte, A., He, J., He, S., Li, Q., Shoemaker, B. A., Thiessen, P. A., Yu, B., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1033 · Cited by 3,249
Convolutional Networks on Graphs for Learning Molecular Fingerprints
Duvenaud, D., Maclaurin, D., Aguilera-Iparraguirre, J., Gómez-Bombarelli, R., Hirzel, T., Aspuru-Guzik, A., & Adams, R. P. (2015) · arXiv · doi:10.48550/arxiv.1509.09292 · Cited by 2,628
ANI-1: an extensible neural network potential with DFT accuracy at force field computational cost
Smith, J. S., Isayev, O., & Roitberg, A. E. (2017) · Chemical Science · doi:10.1039/c6sc05720a · Cited by 1,921
Molecular graph convolutions: moving beyond fingerprints
Kearnes, S., McCloskey, K., Berndl, M., Pande, V., & Riley, P. (2016) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-016-9938-8 · Cited by 1,631
Deep Neural Nets as a Method for Quantitative Structure–Activity Relationships
Ma, J., Sheridan, R. P., Liaw, A., Dahl, G. E., & Svetnik, V. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/ci500747n · Cited by 1,159
DeepTox: toxicity prediction using deep learning
Mayr, A., Klambauer, G., Unterthiner, T., & Hochreiter, S. (2016) · Frontiers in Environmental Science · doi:10.3389/fenvs.2015.00080 · Cited by 1,081 · cited 1×
“Additionally, they are unable to model highly complex interactions within compound molecules [17] and between the compounds and their target proteins.”
BackgroundSrivastava, R. K., Greff, K., & Schmidhuber, J. (2015) · arXiv · doi:10.48550/arxiv.1505.00387 · Cited by 912
Low Data Drug Discovery with One-Shot Learning
Altae-Tran, H., Ramsundar, B., Pappu, A. S., & Pande, V. (2017) · ACS Central Science · doi:10.1021/acscentsci.6b00367 · Cited by 799
Cited by
Artificial intelligence in drug discovery and development
Paul, D., Sanap, G., Shenoy, S., Kalyane, D., Kalia, K., & Tekade, R. K. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2020.10.010 · Cited by 1,695
Artificial intelligence to deep learning: machine intelligence approach for drug discovery
Gupta, R., Srivastava, D., Sahu, M., Tiwari, S., Ambasta, R. K., & Kumar, P. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10217-3 · Cited by 1,473
“DL approaches such as DeepDTA (https:// github. com/ hkmzt rk/ DeepD TA) [314], and PADME [315] predict drug-target binding affinity, which depends on the 3-”
MethodA general model to predict small molecule substrates of enzymes based on machine and deep learning
Kroll, A., Ranjan, S., Engqvist, M. K. M., & Lercher, M. J. (2023) · Nature Communications · doi:10.1038/s41467-023-38347-2 · Cited by 193
Deep learning allows genome-scale prediction of Michaelis constants from structural features
Kroll, A., Engqvist, M. K. M., Heckmann, D., & Lercher, M. J. (2021) · PLOS Biology · doi:10.1371/journal.pbio.3001402 · Cited by 132
Explainable Deep Relational Networks for Predicting Compound-Protein Affinities and Contacts
Karimi, M., Wu, D., Wang, Z., & Shen, Y. (2019) · doi:10.1101/2019.12.28.890103 · Cited by 64
Metadata
- Authors
- Feng, Q., Dueva, E., Cherkasov, A. R., & Ester, M.
- Venue
- arXiv (Cornell University)
- Publisher
- arXiv
- Published
- 2018
- ISSN
- 2331-8422 (ISSN-L)
- arXiv
- 1807.09741
- OpenAlex
- W6986275757
- Cited by
- 79
- References
- 13
- Type
- posted content
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: PADME: A Deep Learning-based Framework for Drug-Target Interaction Prediction. https://app.cochat.ai/papers/10.48550/arxiv.1807.09741
- The paper
- Feng, Q., Dueva, E., Cherkasov, A. R., & Ester, M. (2018). PADME: A Deep Learning-based Framework for Drug-Target Interaction Prediction. arXiv (Cornell University). https://doi.org/10.48550/arxiv.1807.09741
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.